190 related articles for article (PubMed ID: 8100821)
1. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.
Volm M; Drings P; Wodrich W
J Cancer Res Clin Oncol; 1993; 119(9):507-10. PubMed ID: 8100821
[TBL] [Abstract][Full Text] [Related]
2. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
Volm M
Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.
Volm M; Rittgen W; Drings P
Br J Cancer; 1998 Feb; 77(4):663-9. PubMed ID: 9484827
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of oncoproteins in non-small cell lung carcinomas of smokers.
Wodrich W; Volm M
Carcinogenesis; 1993 Jun; 14(6):1121-4. PubMed ID: 8389672
[TBL] [Abstract][Full Text] [Related]
6. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
Volm M; Efferth T; Mattern J
Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
[TBL] [Abstract][Full Text] [Related]
7. Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases.
Volm M; van Kaick G; Mattern J
Clin Exp Metastasis; 1994 Jul; 12(4):329-34. PubMed ID: 7913670
[TBL] [Abstract][Full Text] [Related]
8. Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.
Bajo AM; Schally AV; Krupa M; Hebert F; Groot K; Szepeshazi K
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3836-41. PubMed ID: 11891317
[TBL] [Abstract][Full Text] [Related]
9. Expression of oncoproteins in primary human non-small cell lung cancer and incidence of metastases.
Volm M; Drings P; Wodrich W; van Kaick G
Clin Exp Metastasis; 1993 Jul; 11(4):325-9. PubMed ID: 8100491
[TBL] [Abstract][Full Text] [Related]
10. Combined Expression of c-jun, c-fos, and p53 Improves Estimation of Prognosis in Oral Squamous Cell Carcinoma.
Wang S; Xu X; Xu F; Meng Y; Sun C; Shi L; Zhao E
Cancer Invest; 2016 Sep; 34(8):393-400. PubMed ID: 27558649
[TBL] [Abstract][Full Text] [Related]
11. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins.
Li H; Xie P; Li G; Hao L; Xiong Q
Toxicon; 2009 Jan; 53(1):169-75. PubMed ID: 19041662
[TBL] [Abstract][Full Text] [Related]
12. Immunolocalisation of proto-oncogene expression in mechanically stimulated skeletal muscle.
Lee DM; Dawes NJ; Cox VM; Hesketh JE; Goldspink DF
Biochem Soc Trans; 1995 May; 23(2):329S. PubMed ID: 7672360
[No Abstract] [Full Text] [Related]
13. Changes in proto-oncogene activity in the testis of the frog, Rana esculenta, during the annual reproductive cycle.
Chieffi P; Minucci S; Cobellis G; Fasano S; Pierantoni R
Gen Comp Endocrinol; 1995 Aug; 99(2):127-36. PubMed ID: 8536921
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of multiple oncogenes related to histological grade of astrocytic glioma.
Orian JM; Vasilopoulos K; Yoshida S; Kaye AH; Chow CW; Gonzales MF
Br J Cancer; 1992 Jul; 66(1):106-12. PubMed ID: 1322154
[TBL] [Abstract][Full Text] [Related]
15. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
Volm M; Kästel M; Mattern J; Efferth T
Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
[TBL] [Abstract][Full Text] [Related]
16. C-erbB-2 expression in squamous cell carcinoma of the head and neck.
Field JK; Spandidos DA; Yiagnisis M; Gosney JR; Papadimitriou K; Stell PM
Anticancer Res; 1992; 12(3):613-9. PubMed ID: 1377893
[TBL] [Abstract][Full Text] [Related]
17. Induction of c-fos and c-jun gene products and heat shock protein after brief and prolonged cerebral ischemia in gerbils.
Takemoto O; Tomimoto H; Yanagihara T
Stroke; 1995 Sep; 26(9):1639-48. PubMed ID: 7660411
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
19. Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance.
Riva C; Lavieille JP; Reyt E; Brambilla E; Lunardi J; Brambilla C
Eur J Cancer B Oral Oncol; 1995 Nov; 31B(6):384-91. PubMed ID: 8746269
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.
Chatzistamou I; Schally AV; Sun B; Armatis P; Szepeshazi K
Br J Cancer; 2000 Oct; 83(7):906-13. PubMed ID: 10970693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
